PlainPharmaWatch
CMS PY 2024 Company profile Open Payments data

SPECTRUM PHARMACEUTICALS INC.

SPECTRUM PHARMACEUTICALS INC. reported $434.4K in payments to physicians and teaching hospitals across 774 transactions in CMS Open Payments PY 2024.

Pharmaceutical payment transparency data for SPECTRUM PHARMACEUTICALS INC.. Ranked #753 of 1,797 companies by total payments. Source: CMS Open Payments, Program Year 2024.

Payment Overview

Total Payments

$434.4K

0.0% of all payments

Transactions

774

$561.29 avg

Recipients

748

$580.80 avg

Industry Rank

#753

of 1,797 companies

What the Data Shows for SPECTRUM PHARMACEUTICALS INC.

In Program Year 2024, SPECTRUM PHARMACEUTICALS INC. reported $434,435.40 in payments to 748 physicians and teaching hospitals across 774 individual transactions — an average of $561.29 per transaction and $580.80 per recipient. That total places SPECTRUM PHARMACEUTICALS INC. at rank #753 out of 1,797 companies in the CMS Open Payments database, representing 0.0% of all industry payments reported nationwide for the year. Payment volume at this scale is characteristic of manufacturers with broad prescriber engagement, active clinical research programs, or patented therapies generating ongoing royalty obligations.

The payment mix for SPECTRUM PHARMACEUTICALS INC. spans 3 distinct categories defined by CMS — including general payments (consulting, speaker fees, meals, travel), research payments tied to clinical trials, and ownership or investment interests. The largest single category is "Food and Beverage" at $15.9K, accounting for 3.7% of the company's reported total and 742 transactions. This distribution matters because different payment types carry different regulatory and ethical implications: research funding supports clinical development, while general payments like meals and speaker fees have been studied for their correlation with prescribing patterns in peer-reviewed journals such as JAMA Internal Medicine.

Recipient concentration is another useful lens. The top 5 recipients of payments from SPECTRUM PHARMACEUTICALS INC. received $0.00 combined — 0.0% of the company's total — with the remaining 100.0% distributed across the rest of the 748 recipients. A relatively distributed top-5 share suggests broader engagement across the prescriber community rather than concentration among a handful of high-value relationships. All figures above are drawn directly from the CMS Open Payments Public Use Files for PY2024 and are disclosed under the Physician Payments Sunshine Act; this page summarizes reported financial transfers and does not represent medical advice or judgment about individual prescribing decisions.

Payment Breakdown by Type

SPECTRUM PHARMACEUTICALS INC. made 3 types of payments. "Food and Beverage" accounts for 3.7%.

Food and Beverage $15.9K

3.7% · 742 transactions

Space Rental or Facility Fees $12.4K

2.9% · 2 transactions

Consulting Fee $10.4K

2.4% · 4 transactions

Payment Type Amount Transactions
Food and Beverage $15.9K 742
Space Rental or Facility Fees $12.4K 2
Consulting Fee $10.4K 4

Payment Size Analysis

Average transaction size: $561.29. Average per recipient: $580.80.

Total Amount

$434,435.40

Avg per Transaction

$561.29

Avg per Recipient

$580.80

Payment Transparency Context

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.3B

across 1,797 companies

SPECTRUM PHARMACEUTICALS INC. Share

0.0%

#753 by total payments

Frequently Asked Questions

How much did SPECTRUM PHARMACEUTICALS INC. pay to physicians and hospitals in 2024?
SPECTRUM PHARMACEUTICALS INC. made $434,435.40 in payments to physicians and hospitals in Program Year 2024, across 774 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from SPECTRUM PHARMACEUTICALS INC.?
SPECTRUM PHARMACEUTICALS INC. made payments to 748 physicians and teaching hospitals in 2024. The average payment per recipient was $580.80.
What types of payments did SPECTRUM PHARMACEUTICALS INC. make?
SPECTRUM PHARMACEUTICALS INC. made 3 different types of payments. The largest category was "Food and Beverage" at $15.9K, representing 3.7% of all payments.
How does SPECTRUM PHARMACEUTICALS INC. rank among pharmaceutical companies?
SPECTRUM PHARMACEUTICALS INC. ranks #753 out of 1,797 companies by total payment amount in the CMS Open Payments database for 2024.
What is the average payment size from SPECTRUM PHARMACEUTICALS INC.?
The average transaction from SPECTRUM PHARMACEUTICALS INC. was $561.29 in 2024. The company made 774 total transactions to 748 recipients.
Are the top recipients concentrated for SPECTRUM PHARMACEUTICALS INC.?
The top 5 recipients received $0.00 from SPECTRUM PHARMACEUTICALS INC., representing 0.0% of the company's total payments. Payments are relatively well-distributed across recipients.
Where does the payment data for SPECTRUM PHARMACEUTICALS INC. come from?
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.3B across 1,797 companies.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.